HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R J Peters Selected Research

Vasoflux

8/2001Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R J Peters Research Topics

Disease

5Myocardial Infarction
12/2001 - 11/2000
3Acute Coronary Syndrome
06/2010 - 11/2000
2Hemorrhage
06/2010 - 08/2001
1Intermittent Claudication
03/2012
1Peripheral Arterial Occlusive Disease 1
03/2012
1ST Elevation Myocardial Infarction
06/2010
1Renal Insufficiency (Renal Failure)
06/2010
1Anterior Wall Myocardial Infarction
10/2009
1Atrial Fibrillation
06/2006
1Stroke (Strokes)
06/2006
1Fusariosis
12/2005
1Sarcoma (Soft Tissue Sarcoma)
12/2001
1Avian Leukosis
12/2001
1Tachycardia (Tachyarrhythmias)
04/2001
1Ventricular Tachycardia
04/2001
1Supraventricular Tachycardia
04/2001
1Chest Pain (Chest Pains)
02/2001
1Rupture
11/2000
1Thrombosis (Thrombus)
11/2000
1Venous Thrombosis (Deep-Vein Thrombosis)
11/2000
1Unstable Angina
11/2000
1Stable Angina
11/2000
1Angina Pectoris
10/2000
1Cardiovascular Diseases (Cardiovascular Disease)
10/2000
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2000

Drug/Important Bio-Agent (IBA)

3Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
06/2010 - 11/2000
2Heparin (Liquaemin)FDA LinkGeneric
06/2010 - 08/2001
2AnticoagulantsIBA
06/2006 - 08/2001
2Clopidogrel (Plavix)FDA Link
06/2006 - 08/2001
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2001 - 08/2001
2ThrombinFDA Link
08/2001 - 11/2000
1Fondaparinux (Arixtra)FDA Link
06/2010
1IrbesartanFDA LinkGeneric
06/2006
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
12/2005
1SuspensionsIBA
12/2005
1SilkFDA Link
12/2005
1DiterpenesIBA
12/2005
14-O-carboxymethylascochlorinIBA
12/2005
1Prothrombin (Factor II)IBA
12/2001
1Plasminogen Activators (Plasminogen Activator)IBA
12/2001
1Proteins (Proteins, Gene)FDA Link
12/2001
1Plasminogen Activator Inhibitor 1IBA
12/2001
1factor V LeidenIBA
12/2001
1Fibrinogen (Factor I)FDA Link
12/2001
1SolutionsIBA
12/2001
1LigandsIBA
12/2001
1LDL Receptors (LDL Receptor)IBA
12/2001
1FibrinIBA
08/2001
1VasofluxIBA
08/2001
1Factor X (Stuart Factor)IBA
08/2001
1StreptokinaseFDA Link
08/2001
1Heparin Cofactor IIIBA
08/2001
1Factor IXa (Coagulation Factor IXa)IBA
08/2001
1Adenosine (Adenocard)FDA LinkGeneric
04/2001
1Factor VIIa (Activated Factor VII)IBA
11/2000
1polyethyleneglycol-hirudinIBA
11/2000
1BSF 208791IBA
11/2000
1HirudinsIBA
11/2000
1Thromboplastin (Tissue Factor)IBA
11/2000
1Blood Coagulation Factors (Coagulation Factor)IBA
11/2000
1Lipoproteins (Lipoprotein)IBA
10/2000
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
10/2000
1Triglycerides (Triacylglycerol)IBA
10/2000
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2000
1LipidsIBA
10/2000

Therapy/Procedure

3Therapeutics
06/2010 - 08/2001
1Exercise Therapy (Therapy, Exercise)
03/2012
1Percutaneous Coronary Intervention
10/2009
1Contraindications
06/2006
1Length of Stay
02/2001
1Intravenous Administration
11/2000
1Oral Administration
11/2000